SNDL (SNDL) Competitors $1.80 +0.07 (+4.05%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends SNDL vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. SNDL vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote SNDL (NASDAQ:SNDL) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment, valuation and community ranking. Does the MarketBeat Community favor SNDL or ATNFW? SNDL received 141 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformSNDLOutperform Votes14172.31% Underperform Votes5427.69% 180 Life SciencesN/AN/A Does the media favor SNDL or ATNFW? In the previous week, SNDL's average media sentiment score of 0.55 beat 180 Life Sciences' score of 0.00 indicating that SNDL is being referred to more favorably in the media. Company Overall Sentiment SNDL Positive 180 Life Sciences Neutral Which has stronger earnings & valuation, SNDL or ATNFW? 180 Life Sciences has lower revenue, but higher earnings than SNDL. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$911.22M0.33-$127.91M-$0.31-5.81180 Life SciencesN/AN/AN/AN/AN/A Do analysts recommend SNDL or ATNFW? SNDL presently has a consensus target price of $3.25, suggesting a potential upside of 80.56%. Given SNDL's stronger consensus rating and higher probable upside, analysts plainly believe SNDL is more favorable than 180 Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SNDL or ATNFW more profitable? 180 Life Sciences has a net margin of 0.00% compared to SNDL's net margin of -12.11%. 180 Life Sciences' return on equity of 0.00% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets SNDL-12.11% -8.27% -6.96% 180 Life Sciences N/A N/A N/A SummarySNDL beats 180 Life Sciences on 6 of the 9 factors compared between the two stocks. Ad Diversified Trading InstituteGenesis leading the smart algo revolution?I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$298.84M$377.32M$5.10B$9.07BDividend YieldN/AN/A4.90%4.21%P/E Ratio-5.8132.5691.0817.15Price / Sales0.335.651,113.51116.81Price / CashN/A10.6642.2637.86Price / Book0.291.884.784.78Net Income-$127.91M-$50.37M$119.77M$225.60M7 Day Performance1.12%-3.46%-1.87%-1.23%1 Month Performance-9.77%-6.88%11.46%3.07%1 Year Performance23.29%-6.36%30.53%16.48% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL3.2558 of 5 stars$1.80+4.0%$3.25+80.6%+26.8%$298.84M$911.22M-5.812,516ATNFW180 Life SciencesN/A$0.01+1.2%N/A+25.0%$0.00N/A0.007Gap UpLBPSW4D pharmaN/A$0.04-25.7%N/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.16+6.2%N/A+14.1%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03-42.9%N/A-89.6%$0.00$40,633.000.0040News CoverageGap UpALVOWAlvotechN/A$2.78+1.1%N/A+26.4%$0.00$391.87M0.004Gap DownALVOAlvotech2.6628 of 5 stars$12.04+2.0%$18.00+49.5%+8.7%$0.00$93.38M0.001,026ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06+50.0%N/A+146.3%$0.00N/A0.004Gap UpHigh Trading VolumeACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.09-0.1%N/A+340.0%$0.00$35.36M0.0070Gap UpBTMDWbioteN/A$1.61+15.8%N/A-58.0%$0.00$193.06M0.00N/AGap Up Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNDL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
